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centrosomes are present. This simple scheme explains size control and scaling
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The mechanisms that determine
organelle size remain almost entirely
unknown, but a new study, published
in this issue of Current Biology, on
centrosome size regulation
during Caenorhabditis elegans
embryogenesis has now provided
evidence for an extremely simple
mechanism that may apply to a wide
range of other organelles [1]. Several
theoretical mechanisms for organelle
size control have been described — for
example, molecular rulers, which
represent protein molecules whose
physical size determines the size of
an assembling structure. Rulers have
been shown to control length in
bacterial injection needles [2] and
bacteriophage tails [3]. Ruler
mechanisms require a way to align
the ruler relative to the assembling
structure, and to read out the location
of the assembling structure relative to
the end of the ruler. Other schemes,
such as feedback loops that measure
and adjust organelle size, are even
more complex.
Wouldn’t it be simpler if there was
a way to use the components of the
structure itself as a way to control
its size? Perhaps the simplest way
to control the size of a structure is
a limiting component mechanism, in
which a cell produces a fixed quantity
of precursor, which is then assembled
into the final structure, such that the
structure assembles until the precursor
component is entirely exhausted from
the cytoplasm. The quantity of
precursor component produced by
the cell would thus directly determine
the size of the structure. If precursorconcentration was the same in all cells
at the time that assembly starts, then
larger cells would form proportionally
larger structures since they would
contain more of the limiting component
(Figure 1). This type of model can thus
account for both size control and
scaling of organelle size with cell
size. The limiting component model is
conceptually appealing, but how do we
know if it applies in any given
situation?
One way to test for a limiting
component mechanism is to ask how
the size of the structure varies as
a function of the number of copies of
the structure within one cell. If a cell
makes M molecules of the size-limiting
precursor, which must then be
distributed among N copies of the
organelle, then the average number of
precursor molecules per copy is M/N,
hence the size of the structure should
be proportional to 1/N. Such a
dependence means that, if a cell has
two copies of the structure, the
structures would be half as big as they
would be if the cell had just one. In a cell
with three copies, they would each be
one-third as large. Alternatively, if you
add up the volume of all the copies of
the structure, the total volume should
be constant, independent of the
number of copies. Another hallmark of
a limiting component system is that the
growth rate of the structure should
gradually slow down and reach
a plateau as the limiting component
is exhausted from the cytoplasm.
Structures that cease growth abruptly
when they reach a particular size would
thus not be consistent with this type
of model and one would therefore have
to look for other types of mechanisms,such as rulers, to explain their size
control.
This general idea of a limiting
component model was first proposed
by Kuchka and Jarvik [4] for flagellar
length control in the green alga
Chlamydomonas reinhardtii, a model
system in which it was already known
that reduced expression of precursor
proteins resulted in decreased length
[5]. Measurements in mutants that
change the number of flagella per cell
revealed that flagellar length decreased
in cells with more flagella, but did not
decrease as steeply with increasing
number as the limiting component
model would predict [6]. A simple
limiting component model was thus
ruled out in that system, and indeed
there has not been a clear-cut example
of a limiting component model for
organelle size control until now.
In the new study, Decker and
co-workers [1] examined the size of
centrosomes in developing C. elegans
embryos, in which all protein is
provided maternally, hence the total
quantity of centrosome precursor
protein is fixed during the early
divisions. What they found was that,
as early divisions proceeded,
producing more and more
centrosomes in the embryo,
centrosomes were smaller and smaller
but the total summed volume of the
centrosomes was indeed constant, as
predicted by the limiting component
model.
When individual centrosomes were
examined and compared to the size of
the cells that contained them, it was
found that centrosome volume was
linearly proportional to cell volume.
This also fits with a limiting component
model since the volume of the whole
embryo is constant, and precursor is
presumably distributed during cell
division proportionally to the volume
of the daughter cells, hence larger
cells obtain a proportionally larger
fraction of the initial quantity of
precursor.
Decker et al. [1] further confirmed
that centrosome size was truly cell-size
Figure 1. Limiting component model for organelle size control.
Compared to a large cell (A) which produces a large structure (B), a cell half the size (C) would
start out with half as many monomers and would thus form a structure half the size (D). Such
a mechanism automatically produces linear scaling of organelle volume with cell volume
without requiring any sort of measurement system.
Dispatch
R595dependent and not a consequence
of differences in cell fate that
normally correlate with difference in
cell size, by the elegant use of an
embryo-size-altering mutant in which
all cells are smaller. Comparing cells of
identical cell fate between normal and
small embryos, it was found that cell
size correlated with centrosome size
while cell fate did not [1].
Centrosome growth rate also varied
with cell size, suggesting that
centrosomes in cells with more
precursor grew at a faster rate. This
may seem odd since molecular
assembly rates typically depend on
concentration of precursor, not total
quantity in the cell. Larger cells should
have the same precursor
concentration as smaller cells, and
hence should grow at the same rate, at
least initially. However, as the
centrosomes grow, they deplete
precursors from the cytoplasm. For
any unit increase in centrosome size,
the same quantity of monomers is
consumed from the cytoplasm in each
cell. The resulting change in precursor
concentration will be greater in smaller
cells. Hence, at any particular size of
the centrosome, its instantaneous
growth rate should be lower in smaller
cells, as reported. Overall, the slowing
in growth rate as centrosomes
become larger and reach a plateau is
consistent with the gradual exhaustion
of a limiting component from the
cytoplasm.
The results of Decker et al. [1]
underscore the degree of mechanisticinsight that can be obtained by careful
quantitative analysis. The authors also
went one step beyond and identified
at least one gene, spd-2, whose
expression level appears to control
centrosome size and growth rate.
Spd-2 is a key protein involved in
recruiting pericentriolar material onto
centrioles to form a centrosome [7,8].
In Drosophila, centrosome size is at
least in part determined by the rate of
recruitment of Centrosomin, a
Spd-2-interacting protein [9]. Decker
et al. [1] further provide evidence that
Spd-2 controls centrosome assembly
rate by recruiting Polo-like kinase 1
(PLK1) to the centrosome.
Is Spd-2 the ‘limiting component’ of
the limiting component model?
Probably not. The term limiting
component implies a structural
building block depleted from the
cytoplasm during growth, and whose
final exhaustion from the cytoplasm
determines the point at which growth
ceases. But Spd-2 protein is not
a structural building block of the
centrosome. Rather, Spd-2 apparently
recruits PLK1, which then directs
further assembly, implying that Spd-2
is not itself the building block but
instead facilitates utilization of the
actual centrosome building blocks.
Increased quantities of Spd-2
presumably allow precursor to be
utilized at lower concentrations, thus
allowing centrosomes to grow larger
when more Spd-2 is present.
It is known that centrosome size
affects mitotic spindle length [10].Interestingly, mitotic spindle length
was shown to scale with cell size in
early embryos of Xenopus [11] such
that smaller cells produce shorter
spindles, at least once the size of the
cells drops below some critical size
scale. Is this scaling of spindle length
a by-product of centrosome size
scaling? It would be interesting to know
whether modulation of Spd-2 levels
could alter the scaling relationship
between cell size and spindle length
in that situation.
The limiting precursor model solves
the size control problem by creating
a new problem — how to maintain
a constant total precursor pool. This
is not an issue in early embryos where
all centrosome growth depends on
the initial precursor pool provided by
the mother when the egg is laid. But
will the model still work in post-
embryonic cells that have active
transcription and translation? What
would keep the total precursor
quantity constant in such a case?
Ironically, the simple-sounding limiting
component model may require
sophisticated biological regulatory
mechanisms to control the synthesis
of the limiting component.References
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Set the PaceA new study shows that protein kinase A (PKA) activity establishes a signaling
loop that governs protrusion–retraction cycles in migrating cells. PKA activity
near the leading edge of protrusions phosphorylates RhoA and inhibits its
activity via increased association with RhoGDI.Figure 1. PKA establishes a protrusion–
retraction oscillation by phosphorylating
RhoA.
Protrusions drive actin polymerization (blue
lines) and adhesion formation (pink circles).
Both Rho and PKA are active (*) in protru-
sions. However, PKA phosphorylates RhoA
at the leading edge and removes it from the
membrane by promoting the association
between RhoA and RhoGDI, leading to
sequestration of RhoA in the cytosol. Retrac-
tion formation is characterized by actomy-
osin bundles (blue bundles) and elongating
adhesions (pink ovals).Karen A. Newell-Litwa
and Alan Rick Horwitz*
Oscillatory cycles of membrane
protrusion and retraction at the leading
edge are a common feature of cell
migration. Protrusions are membrane
extensions characterized by dynamic
nascent adhesions and actin
polymerization, while retractions are
contractile events characterized by the
presence of elongating adhesions
associated with actomyosin bundles
(Figure 1) [1–5]. Alternation between
these two phases establishes an
oscillatory wave [1,5].
Despite extensive documentation
of protrusion–retraction cycles in
a variety of migratory cells from
Dictyostelium to mammalian
fibroblasts [1,4], the mechanism that
determines their periodicity is still
unclear, and may vary among cell
types. In general, the proposed
mechanisms postulate that
actomyosin reorganization at the
lamellipodia–lamella interface
establishes protrusion–retraction
cycles [1,5]. The balance between
actin polymerization within
the lamellipodium and actin
de-polymerization and bundling near
the lamellipodia–lamella interface likely
results from separation of activities that
nucleate actin, such as Arp2/3, from
those that depolymerize, bundle and
contract actin, like cofilin and myosin II
[1,4,6]. In mammalian cells, myosin IIA
and myosin light chain kinase move
in waves coincident with retrograde
actin flow [4,5]. Presumably this
phosphorylates and activates
myosin II, which bundles and contracts
actin filaments within the lamellum [4].Inhibition of myosin activity alters the
oscillatory cycles [4,5].
Rho GTPases are signaling
convergence points that regulate the
localized activities involved in actin
dynamics and organization [7].
Guanine nucleotide exchange factors
(GEFs) activate Rho GTPases, leading
to membrane association, while
GTPase-activating proteins (GAPs)
stimulate GTPase activity, leading to
Rho GTPase inhibition [7]. GDP
dissociation inhibitors (GDIs) bind to
inactive Rho, sequestering it in the
cytosol away from the activating GEFs
at the membrane [7]. In a highly
coordinated spatial and temporal
activity profile at the leading edge,
RhoA activity peaks with protrusion
formation, followed by Cdc42 and
Rac activation, which likely initiates
the next protrusion cycle [8].
In spite of the evidence that
coordinated RhoGTPase activity drives
diverse actomyosin assemblies to
produce protrusion–retraction cycles,
an ‘oscillator’ that synchronizes these
dynamic processes is now described
in a recent study. Tkachenko et al. [9]
identified an oscillatory loop between
protein kinase A (PKA) activity and
RhoA–Rho-GDI association that
underlies protrusion–retraction cycles
(Figures 1 and 2). Using fluorescence
resonance energy transfer (FRET)
biosensors that report local PKA and
RhoA activity, they correlated
molecular activity with cell edge
movement, thereby determining the
precise spatial and temporal
activities of these various
components. They also demonstrated
that disruption of these oscillatory
components, using inhibitors andmutants, altered the frequency,
duration, magnitude, and propagation
of the protrusion–retraction cycle.
Previous work identified PKA as an
integrin-associated kinase that is
active at the leading edge and
contributes to cell migration [10,11].
This positioning of PKA activity at the
leading edge coupled with its ability
to regulate actomyosin assembly
through RhoGTPase activity [12] led
Tkachenko et al. [9] to investigate
whether PKA serves as the oscillator
that establishes protrusion–retraction
cycles. Using the cell leading edge as
a spatial and temporal reference point,
they observed that PKA activity
correlated with protrusion formation.
Inhibition of PKA activity disrupted
protrusion–retraction cycles, resulting
